Qsemble Capital Management’s Pfizer PFE Stock Holding History

Qsemble Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.95M	Sell	122,644 -88,473	-42%	-$2.31M	0.38%	92
2026 Q1	$5.93M	Buy	211,117 +105,926	+101%	+$2.82M	0.45%	71
2025 Q4	$2.62M	Sell	105,191 -264,360	-72%	-$6.67M	0.22%	156
2025 Q3	$9.42M	Buy	369,551 +76,826	+26%	+$1.9M	0.92%	12
2025 Q2	$7.1M	Buy	+292,725	New	+$6.83M	0.68%	44
2025 Q1	–	Sell	-248,684	Closed	-$6.6M	–	546
2024 Q4	$6.6M	Buy	248,684 +62,802	+34%	+$1.7M	0.88%	21
2024 Q3	$5.38M	Buy	185,882 +119,176	+179%	+$3.48M	0.99%	11
2024 Q2	$1.87M	Buy	+66,706	New	+$1.84M	0.35%	94
2024 Q1	–	Sell	-41,689	Closed	-$1.2M	–	504
2023 Q4	$1.2M	Buy	+41,689	New	+$1.26M	0.3%	116
2023 Q3	–	Sell	-32,400	Closed	-$1.19M	–	391
2023 Q2	$1.19M	Buy	+32,400	New	+$1.26M	0.84%	42

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Qsemble Capital Management's PFE Position: Q2 2026 in Review

Qsemble Capital Management reduced its Pfizer (PFE) stake by 42% in Q2 2026, selling an estimated $2.31M and leaving 122,644 shares worth $2.95M. The position accounts for 0.38% of the portfolio, ranked #92.

Qsemble Capital Management first reported a position in PFE in Q2 2023 and has held it in 10 quarters since. The position peaked at $9.42M in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Qsemble Capital Management held 122,644 shares of Pfizer worth $2.95M as of Q2 2026.
Qsemble Capital Management sold 88,473 Pfizer shares in Q2 2026, an estimated $2.31M.
Pfizer made up 0.38% of Qsemble Capital Management's portfolio in Q2 2026, its #92 holding.
Qsemble Capital Management first reported a position in Pfizer in Q2 2023 and has held it in 10 quarters since.
Qsemble Capital Management's Pfizer position peaked at $9.42M in Q3 2025.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.